Investigating Inflammasome Gene Activity and Its Impact on Prostate Cancer Outcomes

At the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium, Alireza Ghoreifi, MD, of Duke University Medical Center, highlights his research on characterizing the activity of inflammasome genes and their association with oncological outcomes in prostate cancer.

He expands on the potential clinical applications of his findings, as well as whether targeting specific inflammasome pathways offer new therapeutic strategies for patients with prostate cancer.